CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 198 enrolled
Drug / intervention
Penumbra System with Separator 3D +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01584609
NCT01584609N/ACompleted

A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke

Penumbra Inc.·interventional·Posted Apr 25, 2012·Updated Sep 13, 2018

In Brief

A clinical study evaluating Penumbra System with Separator 3D and Penumbra System alone for Acute Ischemic Stroke From Large Vessel Occlusion. Completed, enrolled 198 participants across 8 sites.

Detailed Summary

This is a prospective, randomized, single blind, concurrent controlled, multi-center study. Patients presenting with symptoms of acute ischemic stroke who have evidence of a large vessel (2.5mm or greater in diameter) occlusion in the cerebral circulation will be assigned to either the Penumbra System with the Separator 3D or the Penumbra System without the Separator 3D. Each treated patient will be followed and assessed for 3 months after randomization. Up to 230 evaluable patients at up to 50 centers presenting with acute ischemic stroke in vessels accessible to the Penumbra Separator 3D System for revascularization within 8 hours of symptom onset. The hypothesis to be tested is that the safety and effectiveness of the Penumbra System with the Separator 3D for the revascularization of large vessel occlusion is not inferior to the Penumbra System alone.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedApr 25, 2012
Enrollment StartApr 1, 2012
Primary CompletionJun 1, 2017
Study CompletionDec 1, 2017
TodayJul 2, 2026
Enrollment to primary: 5.2 yearsPosted 14.2 years ago

Interventions

Penumbra System with Separator 3Ddevice

The Separator 3D is an additional Separator with a new tip configuration for the Penumbra System.

Penumbra System alonedevice

The Penumbra System® is a new generation of neuro-embolectomy devices specifically designed to remove thrombus through aspiration.The treatment paradigm of this System involves the introduction of the Reperfusion Catheter through a guide catheter into the intracranial vasculature, and guided over an appropriate guidewire to the site of primary occlusion. The Reperfusion Catheter is used in parallel with the Separator and an aspiration source (Aspiration Pump) to separate the thrombus and aspirate it from the occluded vessel.